FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

38735811000001103: Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1499391000001111 Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1499401000001114 Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules Has AMP Yargesa 100mg capsules (Piramal Critical Care Ltd) true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules Is a Miglustat 100mg capsules 84 capsule true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules Has specific active ingredient Miglustat true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Yargesa 100mg capsules (Piramal Critical Care Ltd) 84 capsule 4 x 21 capsules Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start